Holen Sie sich die Stockscreener-App
24.78
6.56%
-1.74
Handel nachbörslich:
24.96
0.18
+0.73%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$26.52
Offen:
$26.15
24-Stunden-Volumen:
1.52M
Relative Volume:
1.54
Marktkapitalisierung:
$1.43B
Einnahmen:
$2.25B
Nettoeinkommen (Verlust:
$-1.18B
KGV:
-1.1975
EPS:
-20.6926
Netto-Cashflow:
$19.92M
1W Leistung:
+6.17%
1M Leistung:
+1.47%
6M Leistung:
-21.36%
1J Leistung:
-25.02%
1-Tages-Spanne:
$24.11
$26.60
1-Wochen-Bereich:
$23.23
$27.89
52-Wochen-Spanne:
$21.00
$37.85
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
24.78 | 1.53B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-17 | Fortgesetzt | William Blair | Outperform |
| 2026-01-06 | Eingeleitet | BTIG Research | Buy |
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump - simplywall.st
Enovis (ENOV) Is Up 16.3% After Reaffirming 2026 Outlook And Narrowing Losses – Has The Bull Case Changed? - Sahm
Enovis Corporation 2026 Q1ResultsEarnings Call Presentation (NYSE:ENOV) 2026-05-10 - Seeking Alpha
Enovis Q1 Earnings Call Highlights - Yahoo Finance
Enovis Earnings Call Highlights Recon Strength, Caution - The Globe and Mail
A Quick Look at Today's Ratings for Enovis Corp(ENOV.US), With a Forecast Between $36 to $40 - 富途牛牛
Enovis (ENOV) Q1 2026 Earnings Transcript - AOL.com
Enovis Corporation (NYSE:ENOV) Q1 2026 Earnings Call Transcript - Insider Monkey
Enovis Corporation Q1 2026 earnings preview - MSN
CCORF Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $50 - Moomoo
Enovis Is Maintained at Outperform by Evercore ISI Group - Moomoo
ENOV Maintained by Evercore ISI Group -- Price Target Raised to $36 - GuruFocus
Enovis Q1 2026 slides: earnings beat forecast, margins expand By Investing.com - Investing.com Australia
Enovis: Q1 Earnings Snapshot - theheraldreview.com
Top Enovis (ENOV) Competitors 2026 - MarketBeat
Enovis (ENOV) Quarter Shows Sharply Narrowed Loss Challenging Longstanding Bearish Narratives - simplywall.st
Enovis reaffirms 2026 free cash flow conversion of greater than 25% while absorbing Middle East and tariff headwinds - MSN
Enovis Q1 2026 Deep Dive: EPS Beats by 7.2%, Revenue Up 5% - AlphaStreet
Why Is Enovis (ENOV) Stock Rocketing Higher Today - StockStory
Enovis Q1 2026 slides: earnings beat forecast, margins expand - Investing.com
Earnings call transcript: Enovis Q1 2026 beats forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Enovis Q1 2026 beats forecasts, stock rises - Investing.com
Enovis Shares Rise After Reporting Higher Fiscal Q1 Adjusted EPS, Net Sales, Reiterating Fiscal 2026 Guidance - marketscreener.com
Q1 2026 Enovis Corp Earnings Call Transcript - GuruFocus
MSN Money - MSN
Enovis (ENOV) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Enovis Corp. (NYSE:ENOV) Beats Q1 Estimates, Reaffirms Guidance - ChartMill
Stronger margins at Enovis (NYSE: ENOV) as Q1 2026 loss shrinks sharply - Stock Titan
Earnings Flash (ENOV) Enovis Corporation Reports Q1 Revenue $589.2M, vs. FactSet Est of $572.0M - marketscreener.com
ENOVIS ($ENOV) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (ENOV) Enovis Corporation Posts Q1 Adjusted EPS $0.89 per Share, vs. FactSet Est of $0.81 - marketscreener.com
Enovis : 1Q26 results presentation FINAL - marketscreener.com
Enovis (NYSE:ENOV) Exceeds Q1 CY2026 Expectations - Barchart.com
Enovis (NYSE: ENOV) Q1 2026 sales rise 5%, margins expand and outlook held - Stock Titan
Enovis Q1 sales rise 5%, beat expectations - TradingView
Enovis Announces First Quarter 2026 Results - The Globe and Mail
Enovis Corporation Reaffirms Earnings Guidance for the Year 2026 - marketscreener.com
Enovis Q1 2026 Earnings Call Transcript - MarketBeat
Enovis earnings up next: Can free cash flow silence skeptics? - Investing.com UK
Enovis earnings up next: Can free cash flow silence skeptics? By Investing.com - Investing.com Australia
Enovis (ENOV) Q1 earnings report preview: What to look for - MSN
Enovis (ENOV) Q1 Earnings Report Preview: What To Look For - StockStory
Did William Blair’s FCF-Focused ENOV Call Just Shift Enovis’ Investment Narrative? - Yahoo Finance
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):